Bridging intravenous thrombolysis in patients with atrial fibrillation.

Publikation

Bridging intravenous thrombolysis in patients with atrial fibrillation.

Wissenschaftlicher Artikel/Review - 03.08.2022

Mujanovic Adnan, Kurmann Christoph C, Dobrocky Tomas, Olivé-Gadea Marta, Maegerlein Christian, Pierot Laurent, Mendes Pereira Vitor, Costalat Vincent, Psychogios Marios-Nikos, Michel Patrik, Beyeler Morin, Piechowiak Eike Immo I, Seiffge David Julian, Mordasini Pasquale, Arnold Marcel, Gralla Jan, Fischer Urs, Kaesmacher Johannes, Meinel Thomas Raphael, BEYOND-SWIFT Investigators

Zitation

Mujanovic A, Kurmann C, Dobrocky T, Olivé-Gadea M, Maegerlein C, Pierot L, Mendes Pereira V, Costalat V, Psychogios M, Michel P, Beyeler M, Piechowiak E, Seiffge D, Mordasini P, Arnold M, Gralla J, Fischer U, Kaesmacher J, Meinel T, BEYOND-SWIFT Investigators. Bridging intravenous thrombolysis in patients with atrial fibrillation. Front Neurol 2022; 13:945338.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Front Neurol 2022; 13

Veröffentlichungsdatum

03.08.2022

ISSN (Druck)

1664-2295

Seiten

945338

Kurzbeschreibung/Zielsetzung

40% of acute ischemic stroke patients treated by mechanical thrombectomy (MT) have a clinical history of atrial fibrillation (AF). The safety of bridging intravenous thrombolysis (IVT) (MT + IVT) is currently being discussed. We aimed to analyze the interaction between oral anticoagulation (OAC) status or AF with bridging IVT, regarding the occurrence of symptomatic intracranial hemorrhage (sICH) and functional outcome.